Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

PT-141 (Bremelanotide) vs Oxytocin

Comparison

PT-141 (Bremelanotide) and Oxytocin are two peptides people frequently compare. PT-141 (bremelanotide) is the active ingredient in Vyleesi, FDA-approved for treating low sexual desire in premenopausal women. It works through brain pathways that regulate sexual arousal, unlike… Oxytocin is the active ingredient in Pitocin, FDA-approved to induce or augment labor and prevent postpartum hemorrhage. It also plays a natural role in social bonding and is being studied for…

PT-141 (Bremelanotide) Oxytocin
What it is PT-141 (bremelanotide) is the active ingredient in Vyleesi, FDA-approved for treating low sexual desire in premenopausal women. It works through brain pathways that regulate sexual arousal, unlike… Oxytocin is the active ingredient in Pitocin, FDA-approved to induce or augment labor and prevent postpartum hemorrhage. It also plays a natural role in social bonding and is being studied for…
Primary uses
  • Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women
  • Female sexual dysfunction (desire, arousal, and orgasmic dysfunction) — broader populations
  • Erectile dysfunction (ED) in men — CNS/melanocortinergic mechanism
  • Body weight reduction / caloric intake reduction in obese women
  • Labor induction and augmentation
  • Prevention of postpartum hemorrhage
  • Autism Spectrum Disorder (ASD) — social functioning and core symptoms
  • Postpartum depression — maternal caregiving and mood
How it works It works through brain pathways that regulate sexual arousal, unlike other treatments that act on blood flow. Prescription-only for that indication; also used off-label by men for erectile… It also plays a natural role in social bonding and is being studied for autism, postpartum depression, and social cognition. Prescription-only for obstetric use; intranasal oxytocin for other…
Common dose 1 mg, subcutaneous injection, as needed, approximately 45-60 minutes before sexual activity 24 IU, intranasal, once daily, pre-social interaction or as needed
FDA status FDA-approved (2019) for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women (PMIDs: 31429064, 37365323, 23147017, 33455598, 35147466). Also noted as… FDA-approved synthetic oxytocin (e.g., Pitocin) exists for obstetric indications (labor induction/augmentation, postpartum hemorrhage prevention); no FDA-approved pharmacological treatment for ASD…
Evidence level Human RCT Human RCT